Skip to main content
Erschienen in: Journal of Cancer Education 3/2010

01.09.2010

Obstetrics/Gynecology Residents’ Knowledge of Hereditary Breast and Ovarian Cancer and Lynch Syndrome

verfasst von: Kaylene J. Ready, Molly S. Daniels, Charlotte C. Sun, Susan K. Peterson, Hope Northrup, Karen H. Lu

Erschienen in: Journal of Cancer Education | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Although there have been many studies regarding physicians’ knowledge of hereditary cancer syndromes, very little information exists regarding medical residents’ knowledge of hereditary cancer syndromes. Obstetrics/gynecology residents completed a test which evaluated their knowledge of hereditary breast and ovarian cancer and Lynch syndrome. Areas of relative deficit were identified. Residents indicated a desire and need for more education regarding this topic. Cancer genetics education programs should place more emphasis on the areas in which residents’ appeared to be deficient in order to aid future physicians in the identification of high-risk individuals.
Literatur
1.
Zurück zum Zitat Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van't Veer L, Garber JE et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062CrossRefPubMed Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van't Veer L, Garber JE et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062CrossRefPubMed
2.
Zurück zum Zitat Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23(8):1656–1663CrossRefPubMed Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23(8):1656–1663CrossRefPubMed
3.
Zurück zum Zitat Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van’t Veer L, Garber JE et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616–1622CrossRefPubMed Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van’t Veer L, Garber JE et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616–1622CrossRefPubMed
4.
Zurück zum Zitat Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637CrossRefPubMed Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637CrossRefPubMed
5.
Zurück zum Zitat Annie Yu HJ, Lin KM, Ota DM, Lynch HT (2003) Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev 29(6):461–470CrossRefPubMed Annie Yu HJ, Lin KM, Ota DM, Lynch HT (2003) Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev 29(6):461–470CrossRefPubMed
6.
Zurück zum Zitat Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ et al (2006) Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int J Gynecol Cancer 16(Suppl 1):54–59CrossRefPubMed Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ et al (2006) Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int J Gynecol Cancer 16(Suppl 1):54–59CrossRefPubMed
7.
Zurück zum Zitat Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L et al (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91(17):1475–1479CrossRefPubMed Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L et al (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91(17):1475–1479CrossRefPubMed
8.
Zurück zum Zitat Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5):829–834CrossRefPubMed Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5):829–834CrossRefPubMed
9.
Zurück zum Zitat Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 277(11):915–919CrossRefPubMed Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 277(11):915–919CrossRefPubMed
10.
Zurück zum Zitat Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269CrossRefPubMed Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269CrossRefPubMed
11.
Zurück zum Zitat Acton RT, Burst NM, Casebeer L, Ferguson SM, Greene P, Laird BL et al (2000) Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med 75(8):850–852CrossRefPubMed Acton RT, Burst NM, Casebeer L, Ferguson SM, Greene P, Laird BL et al (2000) Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med 75(8):850–852CrossRefPubMed
12.
Zurück zum Zitat Pichert G, Dietrich D, Moosmann P, Zwahlen M, Stahel RA, Sappino AP (2003) Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer 2(3–4):153–158PubMed Pichert G, Dietrich D, Moosmann P, Zwahlen M, Stahel RA, Sappino AP (2003) Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer 2(3–4):153–158PubMed
13.
Zurück zum Zitat Escher M, Sappino AP (2000) Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 11(9):1131–1135CrossRefPubMed Escher M, Sappino AP (2000) Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 11(9):1131–1135CrossRefPubMed
14.
Zurück zum Zitat Schroy PC 3rd, Barrison AF, Ling BS, Wilson S, Geller AC (2002) Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 97(4):1031–1036CrossRefPubMed Schroy PC 3rd, Barrison AF, Ling BS, Wilson S, Geller AC (2002) Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 97(4):1031–1036CrossRefPubMed
15.
Zurück zum Zitat Wilkins-Haug L, Hill LD, Power ML, Holzman GB, Schulkin J (2000) Gynecologists' training, knowledge, and experiences in genetics: a survey. Obstet Gynecol 95(3):421–424CrossRefPubMed Wilkins-Haug L, Hill LD, Power ML, Holzman GB, Schulkin J (2000) Gynecologists' training, knowledge, and experiences in genetics: a survey. Obstet Gynecol 95(3):421–424CrossRefPubMed
16.
Zurück zum Zitat Koil CE, Everett JN, Hoechstetter L, Ricer RE, Huelsman KM (2003) Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location. Genet Med 5(5):364–369CrossRefPubMed Koil CE, Everett JN, Hoechstetter L, Ricer RE, Huelsman KM (2003) Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location. Genet Med 5(5):364–369CrossRefPubMed
17.
Zurück zum Zitat Barrison AF, Smith C, Oviedo J, Heeren T, Schroy PC 3rd (2003) Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns. Am J Gastroenterol 98(6):1410–1416CrossRefPubMed Barrison AF, Smith C, Oviedo J, Heeren T, Schroy PC 3rd (2003) Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns. Am J Gastroenterol 98(6):1410–1416CrossRefPubMed
18.
Zurück zum Zitat Blazer KR, Grant M, Sand SR, MacDonald DJ, Uman GC, Weitzel JN (2004) Effects of a cancer genetics education programme on clinician knowledge and practice. J Med Genet 41(7):518–522CrossRefPubMed Blazer KR, Grant M, Sand SR, MacDonald DJ, Uman GC, Weitzel JN (2004) Effects of a cancer genetics education programme on clinician knowledge and practice. J Med Genet 41(7):518–522CrossRefPubMed
19.
Zurück zum Zitat Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S et al (2005) Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 105(3):569–574PubMed Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S et al (2005) Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 105(3):569–574PubMed
Metadaten
Titel
Obstetrics/Gynecology Residents’ Knowledge of Hereditary Breast and Ovarian Cancer and Lynch Syndrome
verfasst von
Kaylene J. Ready
Molly S. Daniels
Charlotte C. Sun
Susan K. Peterson
Hope Northrup
Karen H. Lu
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 3/2010
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-010-0063-4

Weitere Artikel der Ausgabe 3/2010

Journal of Cancer Education 3/2010 Zur Ausgabe

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.